These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11530355)

  • 41. The onchocerciasis chronicle: from the beginning to the end?
    Crump A; Morel CM; Omura S
    Trends Parasitol; 2012 Jul; 28(7):280-8. PubMed ID: 22633470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors affecting onchocerciasis transmission: lessons for infection control.
    Cheke RA
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):377-386. PubMed ID: 28117596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [ Onchocerciasis control program in West Africa: socioeconomic development and risk of recrudescence of transmission. 1. Experimental study of the transmission of Onchocerca volvulus strains from Southwestern Sierra Leone by Simulium sirbanum].
    Doucouré K; Bissan Y; Back C; Hougard JM; Agoua H; Guillet P; Konaré M; Quillévéré D
    Ann Soc Belg Med Trop; 1994 Jun; 74(2):113-27. PubMed ID: 7944648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
    Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
    Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
    Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
    Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional characterization and immune recognition of the extracellular superoxide dismutase from the human pathogenic parasite Onchocerca volvulus (OvEC-SOD).
    Ajonina-Ekoti I; Ndjonka D; Tanyi MK; Wilbertz M; Younis AE; Boursou D; Kurosinski MA; Eberle R; Lüersen K; Perbandt M; Breloer M; Brattig NW; Liebau E
    Acta Trop; 2012 Oct; 124(1):15-26. PubMed ID: 22677600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
    Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
    Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling targeted ivermectin treatment for controlling river blindness.
    Poolman EM; Galvani AP
    Am J Trop Med Hyg; 2006 Nov; 75(5):921-7. PubMed ID: 17123988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How long do the effects of ivermectin on adult Onchocerca volvulus persist?
    Kläger S; Whitworth JA; Post RJ; Chavasse DC; Downham MD
    Trop Med Parasitol; 1993 Dec; 44(4):305-10. PubMed ID: 8134772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of ivermectin on the transmission of Onchocerca volvulus in southern Mexico].
    Rodríguez-Pérez MA; Reyes-Villanueva F
    Salud Publica Mex; 1994; 36(3):281-90. PubMed ID: 7940009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The campaign against onchocerciasis in Africa: update].
    Boussinesq M; Hougard JM
    Med Trop (Mars); 1998; 58(3):285-96. PubMed ID: 10088109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficiency of Simulium sanctipauli as a vector of Onchocerca volvulus in the forest zone of Ghana.
    Kutin K; Kruppa TF; Brenya R; Garms R
    Med Vet Entomol; 2004 Jun; 18(2):167-73. PubMed ID: 15189242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa.
    Plaisier AP; Alley ES; Boatin BA; Van Oortmarssen GJ; Remme H; De Vlas SJ; Bonneux L; Habbema JD
    J Infect Dis; 1995 Jul; 172(1):204-10. PubMed ID: 7797912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single nucleotide polymorphisms in β-tubulin selected in Onchocerca volvulus following repeated ivermectin treatment: possible indication of resistance selection.
    Nana-Djeunga H; Bourguinat C; Pion SD; Kamgno J; Gardon J; Njiokou F; Boussinesq M; Prichard RK
    Mol Biochem Parasitol; 2012 Sep; 185(1):10-8. PubMed ID: 22677339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential effects of warmer worms and vectors on onchocerciasis transmission in West Africa.
    Cheke RA; Basáñez MG; Perry M; White MT; Garms R; Obuobie E; Lamberton PH; Young S; Osei-Atweneboana MY; Intsiful J; Shen M; Boakye DA; Wilson MD
    Philos Trans R Soc Lond B Biol Sci; 2015 Apr; 370(1665):. PubMed ID: 25688018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review on medicinal plants and natural compounds as anti-Onchocerca agents.
    Ndjonka D; Djafsia B; Liebau E
    Parasitol Res; 2018 Sep; 117(9):2697-2713. PubMed ID: 30008135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parasitological indicators of onchocerciasis relevant to ivermectin control programmes in the Amazonian focus of Southern Venezuela.
    Vivas-Martínez S; Basáñez MG; Botto C; Villegas L; García M; Curtis CF
    Parasitology; 2000 Nov; 121 Pt 5():527-34. PubMed ID: 11128804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of onchocerciasis.
    Van Laethem Y; Lopes C
    Drugs; 1996 Dec; 52(6):861-9. PubMed ID: 8957156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.